A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs

被引:18
|
作者
Spelman, T. [1 ]
Morris, M. D. [2 ]
Zang, G. [3 ]
Rice, T. [2 ]
Page, K. [4 ]
Maher, L. [5 ]
Lloyd, A. [6 ]
Grebely, J. [5 ]
Dore, G. J. [5 ]
Kim, A. Y. [7 ,8 ]
Shoukry, N. H. [3 ]
Hellard, M. [1 ]
Bruneau, J. [3 ]
机构
[1] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Montreal, CRCHUM, Montreal, PQ H2X 0A9, Canada
[4] Univ New Mexico, Hlth Sci Ctr, Dept Epidemiol Biostat & Prevent Med, Albuquerque, NM 87131 USA
[5] UNSW Australia, Kirby Inst, Sydney, NSW, Australia
[6] UNSW Australia, Sydney, NSW, Australia
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Univ, Sch Med, Boston, MA USA
基金
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词
OPIATE SUBSTITUTION THERAPY; ALCOHOL-CONSUMPTION; RISK BEHAVIOR; LIVER-DISEASE; GLOBAL BURDEN; USERS; EQUIPMENT; IMPACT; HIV; SEROCONVERSION;
D O I
10.1136/jech-2014-205224
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Hepatitis C virus (HCV) testing and counselling have the potential to impact individual behaviour and transmission dynamics at the population level. Evidence of the impact of an HCV-positive status notification on injection risk reduction is limited. The objective of our study was to (1) assess drug and alcohol use and injection risk behaviours following notification; (2) to compare behaviour change in people who inject drugs (PWID) who received a positive test result and those who remained negative; and (3) to assess the effect of age on risk behaviour. Methods Data from the International Collaboration of Incident HIV and HCV Infection in Injecting Cohorts (InC3 Study) were analysed. Participants who were initially HCV seronegative were followed prospectively with periodic HCV blood testing and post-test disclosure and interview-administered questionnaires assessing drug use and injection behaviours. Multivariable generalised estimating equations were used to assess behavioural changes over time. Results Notification of an HCV-positive test was independently associated with a small increase in alcohol use relative to notification of a negative test. No significant differences in postnotification injection drug use, receptive sharing of ancillary injecting equipment and syringe borrowing postnotification were observed between diagnosis groups. Younger PWID receiving a positive HCV test notification demonstrated a significant increase in subsequent alcohol use compared with younger HCV negative. Conclusions The proportion of PWID reporting alcohol use increased among those receiving an HCV-positive notification, increased the frequency of alcohol use postnotification, while no reduction in injection drug use behaviours was observed between notification groups. These findings underscore the need to develop novel communication strategies during post-test notification to improve their impact on subsequent alcohol use and risk behaviours.
引用
收藏
页码:745 / 752
页数:8
相关论文
共 50 条
  • [1] Hepatitis C virus infection in people who inject drugs in Africa
    Shah, Rajiv
    Boucheron, Pauline
    Mandaliya, Kishor
    Kattamaiyo, Alex
    Chevaliez, Stephane
    Shimakawa, Yusuke
    Songok, Elijah
    Lemoine, Maud
    LANCET INFECTIOUS DISEASES, 2020, 20 (03): : 282 - 283
  • [2] Hepatitis C infection in people who inject drugs
    Azim, T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 41 - 42
  • [3] Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely, Jason
    Dore, Gregory J.
    ANTIVIRAL RESEARCH, 2014, 104 : 62 - 72
  • [4] Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence
    Hickman, Matthew
    De Angelis, Daniela
    Vickerman, Peter
    Hutchinson, Sharon
    Martin, Natasha Kaleta
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 576 - 582
  • [5] The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa
    Mahmud, Sarwat
    Mumtaz, Ghina R.
    Chemaitelly, Hiam
    Al Kanaani, Zaina
    Kouyoumjian, Silva P.
    Hermez, Joumana G.
    Abu-Raddad, Laith J.
    ADDICTION, 2020, 115 (07) : 1244 - 1262
  • [6] Recommendations for the management of hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1028 - 1038
  • [7] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137
  • [8] Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada
    Jacka, Brendan
    Roy, Elise
    Hoj, Stine
    Minoyan, Nanor
    Artenie, Andreea Adelina
    Zang, Geng
    Jutras-Aswad, Didier
    Bruneau, Julie
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (12) : 1413 - 1422
  • [9] Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO Study
    Pericot-Valverde, Irene
    Lopes, Snehal S.
    Nahvi, Shadi
    Thrasher, James F.
    Karasz, Alison
    Taylor, Lynn E.
    Mehta, Shruti H.
    Lum, Paula J.
    Tsui, Judith, I
    Page, Kimberly
    Feinberg, Judith
    Kim, Arthur Y.
    Norton, Brianna L.
    Arnsten, Julia H.
    Fernandez-Artamendi, Sergio
    Heo, Moonseong
    Litwin, Alain H.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [10] Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs - a scoping review of the qualitative evidence
    Balsom, Cathy R.
    Farrell, Alison
    Kelly, Deborah V.
    BMC PUBLIC HEALTH, 2023, 23 (01)